ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 450,000 Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) Wednesday said it purchased 450,000 ordinary shares on Aug. 8. MAIN FACTS: -Highest price paid per share was 1507 pence per share. -Lowest price paid per share was 1488 pence per share. -Intends to hold the shares in treasury. -Shares on Wednesday closed at 1507 pence. -Write to Tapan Panchal at Subscribe to WSJ:

Stock News for Glaxosmithkline (GSK)
11/24/201508:38:03Healthcare's Greatest Dividend Stocks
11/24/201506:47:00GSK's Volibris Drug Approved for Combination Treatment
11/23/201511:20:043 High-Risk Dividend Stocks to Avoid
11/19/201509:16:045 Things GlaxoSmithKline PLC Wants You to Know
11/15/201515:00:03Alnylam Pharmaceuticals, Inc. Earnings: 100% Positive (Data)
11/14/201507:01:02Better Dividend Stock: Pfizer vs. GlaxoSmithKline
11/13/201512:39:035 Reasons Roche Thinks It Can Outclass the Competition
11/12/201509:03:02Market-Topping Q3 Results and Positive Wall Street Commentary...
11/09/201509:04:00GlaxoSmithKline Extends Avalon Partnership
11/09/201508:00:00GSK, COPD Foundation and AARC Team Up for #COPDChat, November...
11/05/201506:04:06Report of Foreign Issuer (6-k)
11/04/201519:40:00FDA Approves GlaxoSmithKline's Nucala as Add-on to Treat Severe...
11/04/201519:22:00FDA Approves GlaxoSmithKline's Nucala as Add-on to Treat Severe...
11/04/201517:45:00Press Release: FDA approves Nucala to treat severe asthma
11/03/201511:02:43Report of Foreign Issuer (6-k)
11/03/201510:06:43Report of Foreign Issuer (6-k)
11/03/201508:24:00ViiV Healthcare Announces Positive Headline Results from a Study...
11/03/201508:24:00ViiV Healthcare Announces Positive Headline Results from a Study...
11/03/201508:00:00GlaxoSmithKline, Merck to Trial New Cancer Treatment
11/03/201507:15:00Regulus Expands Development of RG-101 through Clinical Trial...

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations